OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/18/2026
Back to search
Official data from USPTO
AVANTI RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AVANTI RESEARCH
ST13
US500000079413997Class
1, 5, 9
Filing
79413997
Registration
7895563
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/19/2026
Trademark type
Word
Nice classes
1, 5, 9
Filing date
07/23/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
DELGIZZI, RONALD ERNEST
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Croda International Plc
Representatives
Patrick J. Jennings Pillsbury Winthrop Shaw Pittman, LLP
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical compounds in the nature of lipids and lipid mixtures for scientific or research use other than for medical use; lipid compounds for scientific or research use other than for medical use; adjuvantspolymers and excipientssurfactantsdispersantsdiluentsdisintegrantsemulsifiersbindersstabilisers and fillersfor scientific or research use other than for medical use; transfection reagents for scientific or research use other than for medical use; chemical reagents for the delivery of lipids for scientific or research use other than for medical use; standard solutions in the nature of lipids and lipid mixtures for use with analytical techniquesmass spectrometry other than for medical use; lipidssynthetic lipidspolymer modified lipidslipids with modified head groupslipids with modified acyl chainsbioactive lipidsfluorescent lipidsisotope labelled lipidsoxidized lipidslipid extracts from natural sourcesbiological compounds conjugated with modified gold particles for all being for scientific or research use other than for medical use; fatty acidsglycerolipidsglycerophospholipidssphingolipidsglycosphingolipidssaccharolipidssterol lipidsprenol lipidslipid preparations suitable for protein crystallizationlipid preparations suitable for protein solubilizationdetergentsamphiphilic detergentsantibodiesall being for scientific or research use other than for medical use; amino acidspeptidesnucleosidesnucleotides and sugarslipid conjugated versions of the aforesaidall being for scientific or research use other than for medical use; diagnostic and analytical reagents for scientific or research use other than for medical use; formulations in the nature of liposomespre-mixed lipid blends and lipids for bicelle formation comprising lipids for scientific or research use other than for medical use; enzymes for scientific or research use; fluorophores and fluorescent probes for scientific or research use other than for medical use; chemical auxiliary agents as raw materials for manufacturing pharmaceutical preparationsnutrient preparationsfood supplements
Class 5
Lipidssynthetic lipidspolymer modified lipidslipids with modified head groupslipids with modified acyl chainsbioactive lipidsfluorescent lipidsisotope labelled lipidsoxidized lipidslipid extracts from natural sourcesbiological compounds conjugated with modified gold particlesfatty acidsglycerolipidsglycerophospholipidssphingolipidsglycosphingolipidssaccharolipidssterol lipidsprenol lipidslipid preparations suitable for protein crystallizationlipid preparations suitable for protein solubilizationdetergentsamphiphilic detergentsantibodiesactive agentsadditivesexcipients in pharmaceutical preparations; adjuvantspolymers and excipientssurfactantsdispersantsdiluentsdisintegrantsemulsifiersbindersstabilisers and fillersall of the aforesaid being for pharmaceutical or medical use; immunostimulatory compounds for pharmaceutical or medical use; isotopes for medical use; transfection reagents for pharmaceutical or medical use; amino acidspeptidesnucleosidesnucleotides and sugarslipid conjugated versions of the aforesaidall being for pharmaceutical or medical use; drug delivery auxiliary agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Class 9
Apparatus and instruments for scientific research in laboratoriesextrudersmembranes and parts therefor
Publications
History of USPTO decisions and trademark events.
25 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/01/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/31/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/26/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/05/2026
FIMP
FINAL DISPOSITION PROCESSED
03/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/20/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/01/2025
PUBO
PUBLISHED FOR OPPOSITION
07/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/30/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2025
RFNT
REFUSAL PROCESSED BY IB
03/29/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/10/2025
RFRR
REFUSAL PROCESSED BY MPU
03/10/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/22/2025
CNRT
NON-FINAL ACTION WRITTEN
01/21/2025
DOCK
ASSIGNED TO EXAMINER
01/13/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/10/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/02/2025
Continuous trademark protection
Get notified about every new filing that threatens AVANTI RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.